TABLE 1

Subject Demographics and Baseline Characteristics

CharacteristicSubject (n = 110)
Age (y)
 Mean ± SD67.4 ± 7.37
 Range47−90
PSA* (ng/mL)
n63
 Mean ± SD5.87 ± 7.65
 Range0.0−37.4
Prior cancer therapies (n)
 RP only12 (10.9)
 RP + others (excluding RT)4 (3.6)
 RT only39 (35.5)
 RT + others (including RP)41 (37.3)
 Other (neither RP nor RT)14 (12.7)
Gleason score (n)
 Missing28 (25.5)
 31 (0.9)
 5−635 (31.8)
 733 (30.0)
 8−1013 (11.8)
D’Amico classification (n)
 Indeterminate49 (44.5)
 Low6 (5.5)
 Intermediate35 (31.8)
 High20 (18.2)
  • * Before 18F-fluciclovine scan.

  • PSA = prostate-specific antigen; RP = radical prostatectomy; RT = radiotherapy.

  • Data in parentheses are percentages.